# US 2013/0157337 A1 · Template-directed assembly of receptor signaling complexes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157337 A1
- Document ID: US20130157337A1
- Status: Published application
- Kind: A1
- Application number: 13/622,167
- Filed: 2012-09-18
- Published: 2013-06-20
- Earliest claimed: 2003-10-16
- Assignees: University of Massachusetts
- Inventors: Robert M. Weis; Anthony L. Shrout; David J. Montefusco
- Web page: https://patentgrep.com/patent/US20130157337A1

## CPC

- C07K 17/02: Peptides being immobilised on, or in, an organic carrier
- C07K 14/195: from bacteria
- C07K 14/245: Escherichia (G)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Transmembrane receptors in the signaling pathways of bacterial chemotaxis systems influence cell motility by forming noncovalent complexes with the cytoplasmic signaling proteins to regulate their activity. The requirements for receptor-mediated activation of CheA, the principal kinase of the Escherichia coli chemotaxis signaling pathway, can be demonstrated using self-assembled clusters of a receptor fragment (CF) derived from the cytoplasmic domain of the aspartate receptor, Tar. Histidine-tagged Tar CF can be assembled on the surface of unilamellar vesicles via a lipid containing the Nickel-nitrilotriacetic acid moiety as a headgroup. The stability of such a complex can be controlled by the properties of the template including the size and composition, which can be used, for example, to vary the 2-dimensional concentration of receptor fragments. Surface-assembled CF is also found to serve as a substrate for receptor methylation, which is catalyzed by the receptor transferase. Since neither CheA activation nor CF methylation is observed in comparable samples in the absence of vesicles, it is concluded that surface-templating generates the organization among CF subunits required for biochemical activity.

## Claims

### Claim at position 1

1-45. (canceled)

### Claim 46

An in vitro assembly for use in protein assays, said assembly comprising:
a lipid membrane including a first lipid component; and a plurality of a first membrane-associated protein component, said first membrane-associated protein component having a binding affinity for said first lipid component and being coupled with said lipid membrane by interaction with said first lipid component to promote a two dimensional organization of said plurality of first membrane-associated protein component that mimics a natural organization of said first membrane-associated protein component on a cell membrane; wherein said first-membrane-associated protein component, when coupled with said lipid membrane, exhibits a greater biological function than the first membrane-associated protein component in an aqueous medium in the absence of the lipid membrane.

### Claim 47 (depends on 46)

The assembly of claim 46 wherein said membrane further comprises a second lipid component that does not have a binding affinity for said first membrane-associated protein component; and wherein said first and second lipid components are present in relative amounts sufficient to at least partially affect the concentration of said first membrane-associated protein component on said membrane.

### Claim 48 (depends on 47)

The assembly of claim 47 wherein said first lipid component comprises DOGS-NTA-Ni+2, and said second lipid component comprises DOPC, said first and second lipid components present in a ratio from about 3:2 to about 1:20.

### Claim 49 (depends on 47)

The assembly of claim 47 wherein said second lipid component is a substrate for said membrane-associated protein component.

### Claim 50 (depends on 46)

The assembly of claim 46 wherein said membrane is a unilamellar vesicle.

### Claim 51 (depends on 50)

The assembly of claim 50 wherein said vesicle has a diameter dimension up to about 1,000 nm.

### Claim 52 (depends on 46)

The assembly of claim 46 wherein said first membrane-associated protein component comprises a signal protein or a component of a signal protein.

### Claim 53 (depends on 52)

The assembly of claim 52 wherein said signal protein is a phosphotransferase.

### Claim 54 (depends on 46)

The assembly of claim 46 wherein said first membrane-associated protein component is a first transmembrane receptor component.

### Claim 55 (depends on 54)

The assembly of claim 54 wherein said first membrane-associated protein component is a first cytoplasmic domain of a transmembrane receptor.

### Claim 56 (depends on 46)

The assembly of claim 46 wherein said assembly further comprises a plurality of a second membrane-associated protein component coupled to the membrane.

### Claim 57 (depends on 56)

The assembly of claim 56 wherein said first membrane-associated protein component is a first transmembrane receptor component and said second membrane-associated protein component is a second transmembrane receptor component.

### Claim 58 (depends on 57)

The assembly of claim 57 wherein said first membrane-associated protein component is a first cytoplasmic domain of a transmembrane receptor.

### Claim 59 (depends on 58)

The assembly of claim 58 wherein said second membrane-associated protein component is a second cytoplasmic domain of a transmembrane receptor.

### Claim 60

A functional receptor complex, comprising: a lipid membrane including a first lipid component; a plurality of a first receptor protein component; each said first receptor protein component comprising at least one amino acid residue with binding affinity for said first lipid component; and at least one molecule complexed with said first receptor protein component; wherein said receptor complex exhibits a greater biological function than said first receptor protein component and said at least one molecule in an aqueous medium in the absence of the lipid membrane.

### Claim 61 (depends on 60)

The complex of claim 60 wherein said molecule comprises a member selected from the group consisting of a second protein component with binding affinity for said lipid membrane, a second protein component that interacts with said first receptor protein component, an adaptor protein that interacts with said first receptor protein component and combinations thereof.

### Claim 62 (depends on 60)

The complex of claim 60 wherein said molecule comprises a member selected from the group consisting of a second protein component with binding affinity for said lipid membrane and a second protein component that interacts with said first receptor protein component.

### Claim 63 (depends on 62)

The complex of claim 62 wherein one of said first receptor protein component and said second protein component operates as a substrate of another one of said first receptor protein component and said second protein component.

### Claim 64 (depends on 62)

The complex of claim 62 wherein said complex further comprises an adaptor protein.

### Claim 65 (depends on 62)

The complex of claim 62 wherein said complex further comprises one or more additional protein components that operates as a substrate of one of said first receptor protein component and said second protein component.

### Claim 66 (depends on 60)

The complex of claim 60 wherein said membrane is a unilamellar vesicle.

### Claim 67

An in vitro assembly for enhancing the function of a membrane-associated receptor protein component, said assembly comprising: a lipid membrane comprising a first lipid component; a plurality of a first membrane-associated receptor protein component, said first membrane-associated receptor protein component having a binding affinity for said first lipid component and being coupled with said first lipid component; wherein said coupling enhances receptor function of the first membrane-associated receptor protein component compared to receptor function exhibited by the first membrane-associated receptor protein component in an aqueous medium in the absence of the lipid membrane.
